KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Assets (2016 - 2025)

Historic Return on Assets for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.01%.

  • TherapeuticsMD's Return on Assets fell 100.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 400.0% up from last year.
  • TherapeuticsMD's Return on Assets amounted to 0.01% in Q3 2025, which was down 100.0% from 0.0% recorded in Q2 2025.
  • TherapeuticsMD's Return on Assets' 5-year high stood at 1.88% during Q1 2023, with a 5-year trough of 0.82% in Q3 2021.
  • Its 5-year average for Return on Assets is 0.1%, with a median of 0.0% in 2025.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 23500bps in 2023, then plummeted by -19000bps in 2024.
  • TherapeuticsMD's Return on Assets (Quarter) stood at 0.42% in 2021, then surged by 336bps to 0.99% in 2022, then tumbled by -106bps to 0.05% in 2023, then soared by 106bps to 0.0% in 2024, then soared by 78bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.0% for Q2 2025, and 0.0% during Q1 2025.